Mizoribine is an imidazole nucleoside immunosuppressant used clinically to prevent organ rejection following renal transplantation by inhibiting lymphocyte proliferation through the suppression of de novo… Read more





Mizoribine is an imidazole nucleoside immunosuppressant used clinically to prevent organ rejection following renal transplantation by inhibiting lymphocyte proliferation through the suppression of de novo purine synthesis. This category provides access to high-quality reference standards for Mizoribine, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds such as Mizoribine-13C3-15N. These compounds are essential components for pharmaceutical laboratories engaged in impurity profiling, method development, and validation studies. By utilizing certified reference materials and stable isotope-labelled standards, analysts can ensure the accuracy of their analytical testing and maintain rigorous quality control protocols throughout the drug manufacturing lifecycle. These materials facilitate precise identification and quantification of impurities and degradation products, supporting compliance with regulatory standards for immunosuppressive therapeutic agents.